Literature DB >> 8900198

Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase.

J Liu1, N W Shworak, L M Fritze, J M Edelberg, R D Rosenberg.   

Abstract

The cellular generation of proteoglycans with anticoagulant heparan sulfate (HSPGact) is determined by microsomal "HSact conversion activity" that functions in concert with the sulfate donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to convert nonanticoagulant heparan sulfate (HSinact) to anticoagulant heparan sulfate (HSact) (Shworak, N. W., Fritze, L. M. S., Liu, J., Butler, L. D., and Rosenberg, R. D. (1996) J. Biol. Chem. 271, 27063-27071). Suspension cultures of L-33(+) cells in serum-free medium produce HSPGact and secrete HSact conversion activity. The secreted protein exhibiting HSact conversion activity was isolated by subjecting large volumes of conditioned suspension culture medium to heparin-AF Toyopearl affinity chromatography, Mono Q-FPLC, TSK SW3000-HPLC, and 3',5'-ADP-agarose affinity chromatography. The final product was purified approximately 700,000-fold relative to cellular material with a 5% overall recovery of HSact conversion activity. The isolated protein migrated on SDS-polyacrylamide gel electrophoresis as a broad band of Mr = 46,000 and co-migrated on nondenaturing acidic pH gel electrophoresis with HSact conversion activity. The purified component was identified as heparan sulfate D-glucosaminyl 3-O-sulfotransferase because it transferred sulfate from [35S]PAPS to the 3-O-position of D-glucosamine and D-glucosamine 6-O-sulfate of HSact precursor and HSinact precursor to produce nearly equivalent amounts of labeled HSact and HSinact. The exhaustive modification of wild-type LTA cell [35S]HS with either microsomal HSact conversion activity or purified enzyme increased HSact content from 9 to approximately 36%, which indicates that microsomal HSact conversion activity predominantly reflects the level of a 3-O-sulfotransferase that converts HSact precursor into HSact. The kinetic parameters of purified 3-O-sulfotransferase were determined for modification of HSact precursor and HSinact precursor. The apparent KM* and Vmax* with respect to PAPS concentration for sulfation of HSact precursor and HSinact precursor were 2.4 microM and 23 fmol of sulfate/min/ng of enzyme and 2.1 microM and 38 fmol of sulfate/min/ng of enzyme, respectively. There was substrate inhibition of the sulfation reaction at elevated HS concentration. The apparent KM* and Vmax* with respect to GAG concentration for sulfation of HSact precursor and HSinact precursor were 16 nM and 120 fmol of sulfate/min/ng of enzyme and 17 nM and 240 fmol of sulfate/min/ng of enzyme, respectively. The observation that purified 3-O-sulfotransferase catalyzes sulfation of HSact precursor and HSinact precursor in conjunction with a documented discordant regulation of 3-O-sulfate content in HSinact and HSact suggests that two discrete forms of the enzyme may exist.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900198     DOI: 10.1074/jbc.271.43.27072

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

Authors:  Sassan HajMohammadi; Keiichi Enjyoji; Marc Princivalle; Patricia Christi; Miroslav Lech; David Beeler; Helen Rayburn; John J Schwartz; Samad Barzegar; Ariane I de Agostini; Mark J Post; Robert D Rosenberg; Nicholas W Shworak
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate.

Authors:  Xianxuan Zhou; Kasemsiri Chandarajoti; Truong Quang Pham; Renpeng Liu; Jian Liu
Journal:  Glycobiology       Date:  2011-01-11       Impact factor: 4.313

Review 3.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  A synthetic heparan sulfate oligosaccharide library reveals the novel enzymatic action of D-glucosaminyl 3-O-sulfotransferase-3a.

Authors:  Thao Kim Nu Nguyen; Sailaja Arungundram; Vy My Tran; Karthik Raman; Kanar Al-Mafraji; Andre Venot; Geert-Jan Boons; Balagurunathan Kuberan
Journal:  Mol Biosyst       Date:  2011-11-24

5.  Unraveling the specificity of heparanase utilizing synthetic substrates.

Authors:  Sherket B Peterson; Jian Liu
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

6.  Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.

Authors:  Andrew J Schork; Yunpeng Wang; Rahul S Desikan; Wesley K Thompson; Abbas Dehghan; Paul M Ridker; Daniel I Chasman; Linda K McEvoy; Dominic Holland; Chi-Hua Chen; David S Karow; James B Brewer; Christopher P Hess; Julie Williams; Rebecca Sims; Michael C O'Donovan; Seung Hoan Choi; Joshua C Bis; M Arfan Ikram; Vilmundur Gudnason; Anita L DeStefano; Sven J van der Lee; Bruce M Psaty; Cornelia M van Duijn; Lenore Launer; Sudha Seshadri; Margaret A Pericak-Vance; Richard Mayeux; Jonathan L Haines; Lindsay A Farrer; John Hardy; Ingun Dina Ulstein; Dag Aarsland; Tormod Fladby; Linda R White; Sigrid B Sando; Arvid Rongve; Aree Witoelar; Srdjan Djurovic; Bradley T Hyman; Jon Snaedal; Stacy Steinberg; Hreinn Stefansson; Kari Stefansson; Gerard D Schellenberg; Ole A Andreassen; Anders M Dale
Journal:  Circulation       Date:  2015-04-10       Impact factor: 29.690

Review 7.  Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.

Authors:  Nicholas W Shworak; Sassan HajMohammadi; Ariane I de Agostini; Robert D Rosenberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

8.  The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues.

Authors:  Roger Lawrence; Tomio Yabe; Sassan Hajmohammadi; John Rhodes; Melissa McNeely; Jian Liu; Edward D Lamperti; Paul A Toselli; Miroslaw Lech; Patricia G Spear; Robert D Rosenberg; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2007-03-30       Impact factor: 11.583

Review 9.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

Review 10.  The design and synthesis of new synthetic low-molecular-weight heparins.

Authors:  K Chandarajoti; J Liu; R Pawlinski
Journal:  J Thromb Haemost       Date:  2016-04-15       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.